Current Genetics 2004, 45:214–224.CrossRefPubMed Authors’ contributions AS performed microarray analysis, constructed mutant strains, did PCR analysis and contributed to analysis of array data. TA cultured and characterized biofilms, and collected and purified RNA for array analysis. KM contributed to analysis of array data, particularly to K means analysis. SB performed TEM analysis. AN was primarily responsible for the design and analysis of the Tozasertib cost microarray experiments and especially the comparison with other data sets. PAS performed SEM and microscopy, contributed to array analysis and was primarily responsible for biofilm experimental design.”
“Background Pseudomonas aeruginosa

is an opportunistic, non-fermentative, gram-negative rod which is an important cause of nosocomial infection leading to septicemia and death [1]. The mortality rate is higher than bacteremias caused by other gram-negative opportunistic pathogens. One of the most important features of the bacterium is its resistance to various antibacterial agents [2,3], and even newly developed antibiotics have failed to reduce the mortality rate associated with this organism see more [4]. There is increasing interest in bacterial virulence factors

as a basis for effective vaccines and immunotherapies. Several extracellular products fromP. aeruginosa such as exotoxin A, exoenzyme S, phospholipase and hemolysins have been studies as potential virulence factors [5]. The role of exotoxin A

in the mortality of experimentally-infected animals has been demonstrated [6] and the LD50 of the exotoxin reported to be 60–80 ng/mouse [7]. Following a single injection of 80 ng of exotoxin A, necrosis, and Farnesyltransferase cellular swelling were detected in liver within 48 h [7]. Hemorrhage in the lungs and necrosis in the kidneys were also reported [7,8]. In eukaryotic cells, when exotoxin A turns into an activated enzyme, transfer of an adenosine diphosphate ribose moiety from NAD led to inactivation of elongation factor 2 and inhibition of protein synthesis [7]. selleck inhibitor Furthermore, the pre-existence of a high titer of anti-exotoxin A antibody reportedly increased the survival rate in patients withP. aeruginosa bacteremia [9]. This study was performed to determine the immunogenicity of a toxoid produced from exotoxin A ofP. aeruginosa in a mouse burn model. Methods Preparation of exotoxin A A toxigenic strain ofP. aeruginosa (PA 103) was used for exotoxin A preparation. Exotoxin A was partially purified according to the method described by Pollack et al. [10] and Homma et al. [11].P. aeruginosa was inoculated into tryptic soy agar and incubated at 37°C for 24 h in ambient conditions. The growth product of the slant cultures was inoculated into 500 mL of Muller-Hinton broth and incubated at 37°C for another 24 h in ambient conditions.